Kim Annink

273 General discussion / Conclusions & clinical implications / Future directions 52 . Mcgaurn S, Davis LE, Krawczeniuk MM, Murphy JD, Jacobs ML, Norwood WI, et al. The Pharmacokinetics of Injectable Allopurinol in Newborns With the Hypoplastic Left Heart Syndrome. Pediatrics. 1994;94(6):820–3. 53 . Haan TR De, Bijleveld YA, Lee JH Van Der, Groenendaal F, Broek MPH Van Den, Dijk PH, et al. Pharmacokinetics and pharmacodynamics of medication in asphyxiated newborns during controlled hypothermia. The PharmaCool multicenter study. BMC Pediatr. 2012;12:45–52. 54 . Favié LMA, Groenendaal F, van den Broek MPH, Rademaker CMA, De Haan TR, Van Straaten HLM, et al. Pharmacokinetics of morphine in encephalopathic neonates treated with therapeutic hypothermia. PLoS One. 2019;14(2):1–17. 55 . Shah P, Riphagen S, Beyene J, Perlman M. Multiorgan dysfunction in infants with post-asphyxial hypoxic-ischaemic encephalopathy. Arch Dis Child Fetal Neonatal Ed. 2004;89(2):152–5. 56 . Van Den Broek MPH, Groenendaal F, Egberts ACG, Rademaker CMA. Effects of hypothermia on pharmacokinetics and pharmacodynamics: A systematic review of preclinical and clinical studies. Clin Pharmacokinet. 2010;49(5):277–94. 57 . Kaandorp JJ, Derks JB, Oudijk MA, Torrance HL, Harmsen MG, Nikkels PGJ, et al. Antenatal Allopurinol Reduces Hippocampal Brain Damage After Acute Birth Asphyxia in Late Gestation Fetal Sheep. Reprod Sci. 2014;21(2):251–9. 58 . Yoshida S, Rudan I. Europe PMC Funders Group Newborn health research priorities beyond 2015. Lancet. 2014;384(9938):e27–9. 59 . Ditchfield M. 3 T MRI in paediatrics: Challenges and clinical applications. Eur J Radiol. 2008;68:309–19. 60 . Wu TW, McLean C, Friedlich P, Wisnowski J, Grimm J, Panigrahy A, et al. Brain Temperature in Neonates with Hypoxic-Ischemic Encephalopathy during Therapeutic Hypothermia. J Pediatr 2014;165(6):1129–34. 61 . Kraff O, Quick HH. 7T: Physics, Safety, and Potential Clinical Applications. J Magn Reson Imaging. 2017;46:1573–89. 62 . Khan T, Stewart M, Blackman S, Rousseau R, Donoghue M, Cohen K, et al. Accelerating Pediatric Cancer Drug Development: Challenges and Opportunities for Pediatric Master Protocols. Ther Innov Regul Sci. 2019;53(2):270–8. 63 . Redman MW, Starr DA. The Master Protocol Concept. Semin Oncol. 2015;42(5):724–30. 64 . Balevic S, Cohen-Wolkowiez M. Innovative Study Designs Optimizing Clinical Pharmacology Research in Infants and Children. J Clin Pharmacol. 2017;58:S58–72. 65 . Janvier A, Bourque CJ, Dahan S, Robson K, Barrington KJ. Integrating Parents in Neonatal and Pediatric Research. Neonatology. 2019;115(4):283–91. 12